(Q44228337)

1 December 2017

title

Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering (English)

1 reference

1 December 2017

1 reference

Sabu J George

1

1 reference

1 December 2017

Abhay J Dhond

series ordinal

2

1 reference

1 December 2017

Skip M Alderson

series ordinal

3

1 reference

1 December 2017

Michael D Ezekowitz

series ordinal

4

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

American Journal of Cardiology

1 December 2017

published in

1 reference

1 December 2017

volume

90

1 reference

1 December 2017

issue

11

1 reference

1 December 2017

page(s)

1237-1239

1 reference

Incidence and occurrence of total (first-ever and recurrent) stroke

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

VASCULAR DISEASE OF THE BRAIN--EPIDEMIOLOGIC ASPECTS: THE FARMINGHAM STUDY.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Relation of blood pressure, serum lipids, and smoking to the risk of cerebral stroke. A longitudinal study in Eastern Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

HDL-Cholesterol, total cholesterol, and the risk of stroke in middle-aged British men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

The evolving role of statins in the management of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Inhibition of tissue-factor-mediated thrombin generation by simvastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Statins for stroke: the second story?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Rho-GTPase-dependent platelet-neutrophil interaction affected by HMG-CoA reductase inhibition with altered adenosine nucleotide release and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Effect of atorvastatin on plasminogen activator inhibitor type-1 synthesis in human monocytes/macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Vastatins Inhibit Tissue Factor in Cultured Human Macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

The effects of hydroxy-methyl-glutaryl co-enzyme A reductase inhibitors on platelet thrombus formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Regulation of endothelial nitric oxide synthase and endothelin-1 expression by fluvastatin in human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

The medical economics of stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902841-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(02)02841-2

1 reference

1 December 2017

1 reference